Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb open-label study of intraprostatic PRX302 in localized prostate cancer
2016-004694-41Phase 2Terminated
- Sponsor
- Sophiris Bio Inc.
- Start
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of topsalysin in prostate cancer (PCa), sponsored by Sophiris Bio Inc.. Started Dec 2016; status: terminated.
02
Drugs
topsalysin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2016-004694-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004694-41.